Sam Fender tops this week's Official Trending Chart with Arm's Length. Having already secured the biggest opening week of 2025 so far, and currently tracking for Number 1 with his third studio ...

Lady Gaga’s MAYHEM makes a mighty debut at Number 1 on the Official Albums Chart. Gaga’s sixth solo studio album – and eighth overall including her collaborations with the late Tony ...

BLACKPINK’s Jennie has made a historic debut on the United Kingdom’s Official Albums Chart! On March 14 local time, the United Kingdom’s Official Charts (widely regarded as the U.K ...

For those looking to keep their glucose levels balanced, especially people with diabetes or who want to eat more healthily, ...

BLACKPINK’s Lisa has made her solo debut on the United Kingdom’s Official Albums Chart! On March 7 local time, the Official Charts (widely regarded as the U.K. equivalent to Billboard’s U.S ...

There was variation in CGM bias by postprandial test, with the glycemic index for commercial fruit smoothie higher with CGM than capillary (69 vs 53). There was variation by participant in the ...

VP and Godfather of Talent Optimization at The Predictive Index. "As organizations face unprecedented talent challenges, PI is proud to provide the behavioral insights and strategic frameworks ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

WESTWOOD, Mass.--(BUSINESS WIRE)--The Predictive Index (PI), the data-driven HR platform used to hire top performers, develop effective managers and retain your people, announces its presence at ...

The Predictive Index (PI), the data-driven HR platform used to hire top performers, develop effective managers and retain your people, announces its presence at Transform, the premier conference ...

"Transform has become the essential gathering for forward-thinking leaders shaping the future of HR and workplace innovation," said Matt Poepsel, PhD, VP and Godfather of Talent Optimization at The ...

The FDA has approved Merck's (NYSE:MRK) STEGLATRO (ertugliflozin) for glycemic control in adults with type 2 diabetes (T2D). The... The FDA approves Merck's (MRK -0.2%) Steglujan (ertugliflozin ...